Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are collecting detailed information about patients with venous thromboembolism (VTE), which includes blood clots in veins such as deep-vein thrombosis and pulmonary embolism. The project aims to improve doctors' understanding of VTE, especially in patients often excluded from clinical trials, like pregnant women, elderly individuals, cancer patients, and those with other complex health issues. The goal is to reduce deaths, clot recurrence, bleeding problems, and artery-related events by sharing this knowledge widely. The study involves gathering extensive data on each patient's health status, treatments, and outcomes during the first three months of therapy. This registry is available online to help doctors quickly find information on patients with similar medical profiles and make informed decisions about managing high-risk individuals. There are no specific interventions being tested; instead, the focus is on collecting real-world patient data. Participants provide informed consent and are followed for at least three years to monitor for new clot events and complications. Researchers track recurrences of VTE, bleeding episodes, and deaths, aiming to create tools that predict which patients are most at risk for problems. This ongoing data collection supports improving care and guiding treatment decisions for diverse patient groups over time.
Actively Recruiting
This research aims to find out if a nursing educational program can help reduce anxiety in patients scheduled for treatment in a hyperbaric chamber. The study compares this new nursing education approach with the usual care given to patients before their treatment. It focuses on patients who will receive hyperbaric chamber therapy and evaluates anxiety levels using a standardized questionnaire during the first treatment week. Participants in the intervention group will receive an educational brochure on the day their treatment is prescribed, containing key information about the hyperbaric chamber. On the first day of treatment, they will arrive half an hour early to receive a detailed nursing explanation supported by audiovisual materials about the chamber's operation and important considerations during treatment. The control group will get the standard brief explanation currently provided before entering the chamber. Throughout the study, researchers will assess anxiety using the State-Trait Anxiety Inventory (STAI) questionnaire during the first week of treatment in the chamber. Participants will be monitored for anxiety levels as the main outcome. The study includes adults aged 18 to 100 who understand Spanish or Catalan and meet cognitive criteria. Those who experience fear inside the chamber are excluded from participation.